Menu

Back to Medication Guide

Tiotropium

Generic Name: Tiotropium

Brand Names: Spiriva

Tiotropium is used to treat chronic obstructive pulmonary disease (COPD). It is available as Spiriva and is commonly prescribed in the respiratory category.

RespiratoryAnticholinergicsCOPD

Drug Class

Long-Acting Muscarinic Antagonist (LAMA) — Anticholinergic Bronchodilator

Pregnancy

Not formally categorized; use during pregnancy only if clearly needed — limited human data

Available Forms

18 mcg inhalation capsule (for HandiHaler device), 1.25 mcg/actuation inhalation spray (Respimat — 2 puffs = 2.5 mcg), 2.5 mcg/actuation inhalation spray (Respimat — 2 puffs = 5 mcg)

Dosage Quick Reference

These are general dosage guidelines. Your doctor will determine the appropriate dose for your specific situation.

ConditionStarting DoseTypical Maintenance Dose
COPD maintenance (HandiHaler)18 mcg (1 capsule) inhaled once daily18 mcg once daily
COPD maintenance (Respimat)2 puffs of 2.5 mcg (5 mcg total) once daily5 mcg once daily
Asthma maintenance (Respimat, ≥6 years)2 puffs of 1.25 mcg (2.5 mcg total) once daily2.5 mcg once daily

Side Effects

Common Side Effects:

  • Dry mouth
  • Upper respiratory tract infection
  • Sinusitis
  • Pharyngitis
  • Urinary tract infection
  • Constipation

Serious Side Effects:

  • Paradoxical bronchospasm
  • Urinary retention
  • Worsening narrow-angle glaucoma
  • Hypersensitivity reactions (angioedema)

Drug Interactions

Major Drug & Food Interactions

  • Other anticholinergic medications (ipratropium, umeclidinium, glycopyrrolate, oxybutynin, benztropine): Additive anticholinergic effects including dry mouth, urinary retention, constipation, and increased intraocular pressure; avoid concurrent use of other inhaled anticholinergics.
  • Short-acting beta-agonists (albuterol): Safe and commonly used together for COPD; no adverse interaction — albuterol remains the rescue inhaler.
  • Potassium-sparing diuretics or potassium supplements: Monitor electrolytes, as anticholinergic effects on GI and renal function may alter potassium handling indirectly.
  • Tricyclic antidepressants (amitriptyline, nortriptyline): Additive anticholinergic effects; increased risk of urinary retention, constipation, and cognitive impairment, especially in older adults.

Additional Information

Tiotropium is a long-acting muscarinic antagonist (LAMA) used for maintenance treatment of COPD and asthma. It provides sustained bronchodilation for 24 hours with once-daily dosing.

Mechanism of Action

Tiotropium works through anticholinergic mechanisms:

  • Muscarinic receptor antagonism: Blocks M1, M2, and M3 receptors
  • Prolonged M3 binding: Very slow dissociation from M3 receptors (>35 hours)
  • Bronchodilation: M3 blockade in airway smooth muscle causes relaxation
  • Reduced mucus secretion: M3 inhibition decreases goblet cell activity
  • 24-hour duration: Long receptor binding enables once-daily dosing

The kinetic selectivity for M3 over M2 receptors results in sustained bronchodilation without significant cardiac effects.

Available Formulations

  • Spiriva HandiHaler: Tiotropium bromide powder 18 mcg capsules for inhalation
  • Spiriva Respimat: Tiotropium bromide solution 1.25 mcg/actuation and 2.5 mcg/actuation (soft mist inhaler)

Medical Uses

FDA-Approved Indications:

  • Long-term, once-daily maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema
  • Long-term, once-daily maintenance treatment of asthma in patients ≥6 years (Spiriva Respimat)
  • Reduction of COPD exacerbations

Dosing Guidelines

COPD (Adults):

  • HandiHaler: One 18 mcg capsule inhaled once daily via HandiHaler device
  • Respimat: Two inhalations of 2.5 mcg (5 mcg total) once daily

Asthma (Adults and children ≥6 years):

  • Respimat: Two inhalations of 1.25 mcg (2.5 mcg total) once daily

Administration:

  • Inhale at same time each day
  • HandiHaler capsules are for inhalation only; do not swallow
  • Prime Respimat before first use

Important Safety Information

Contraindications:

  • Known hypersensitivity to tiotropium, ipratropium, or atropine derivatives
  • History of hypersensitivity to any component (including milk protein for HandiHaler)

Warnings and Precautions:

  • Not for acute episodes: Not a rescue medication
  • Paradoxical bronchospasm: May occur; discontinue and use alternative therapy
  • Urinary retention: Use with caution in patients with narrow-angle glaucoma or urinary retention
  • Narrow-angle glaucoma: May worsen; avoid getting product in eyes
  • Renal impairment: Use with caution in severe impairment

Drug Interactions

  • Other anticholinergics (ipratropium): Avoid concurrent use; additive anticholinergic effects
  • Other inhaled medications: Generally compatible; coordinate with other controller medications

Special Populations

  • Hepatic Impairment: No adjustment needed (minimal hepatic metabolism)
  • Renal Impairment: Use with caution in moderate to severe impairment (CrCl ≤50 mL/min); monitor for anticholinergic side effects
  • Elderly: No specific adjustment; more susceptible to anticholinergic effects
  • Pregnancy: Limited data; use only if benefit outweighs risk
  • Lactation: Unknown if excreted in milk
  • Pediatric: Respimat approved for asthma in children ≥6 years

Frequently Asked Questions

Albuterol is a short-acting rescue inhaler (beta-agonist) that works within minutes and lasts 4–6 hours for acute symptom relief. Tiotropium is a long-acting maintenance inhaler (anticholinergic) that takes 30 minutes to start working but provides 24-hour bronchodilation. Tiotropium is taken daily to prevent symptoms, not for acute rescue.
Absolutely not. The tiotropium capsule (for the HandiHaler device) is designed for inhalation only. Place the capsule in the HandiHaler device, pierce it by pressing the button, then inhale the powder through the mouthpiece. Never swallow the capsule, as the medication will not work if taken orally.
The most common side effect is dry mouth, which occurs in about 5–16% of patients. Other side effects include sore throat, upper respiratory infection symptoms, constipation, and urinary difficulty. Serious but rare side effects include paradoxical bronchospasm, worsening of narrow-angle glaucoma, and urinary retention.
Yes. Tiotropium Respimat (1.25 mcg per puff) is FDA-approved as add-on maintenance therapy for asthma in patients aged 6 and older whose symptoms are not adequately controlled on inhaled corticosteroids. It is not a first-line asthma treatment and is always used in addition to an inhaled corticosteroid.
Store capsules in the sealed blister packaging until ready to use. Do not expose to extreme heat or moisture. Capsules removed from the blister should be used immediately. The Respimat inhaler should be discarded 3 months after first use, even if there is medication remaining.

Questions to Ask Your Doctor

Consider discussing these topics at your next appointment:

  • Is tiotropium the right maintenance inhaler for my stage of COPD?
  • Should I be using tiotropium alone or in combination with an inhaled corticosteroid?
  • Am I using my HandiHaler or Respimat device correctly?
  • Could my urinary or prostate problems be affected by tiotropium?
  • When should I use my albuterol rescue inhaler versus my tiotropium maintenance inhaler?

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.

Questions About This Medication?

Talk to your doctor or pharmacist about whether Tiotropium is right for you.

Contact Us

Call: (727) 820-7800